IL17A and psoriasis: The shRNA-mediated knockdown of LINC01176 in the IMQ-induced mouse model of psoriasis also had therapeutic effects by reducing plaque formation and the expression of inflammatory cytokines, such as IL-17, IL-23, TNF-α, and IL-36γ [51].